Výsledky vyhledávání - "Brijesh Bhambi"

Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection

Publikováno v: The American Journal of Medicine

Approximately 9 months of the severe acute respiratory syndrome coronavius-2 (SARS-CoV-2 [COVID-19]) spreading across the globe has led to widespread COVID-19 acute hospitalizations and death. The rapidity and highly communicable nature of the SARS-C

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73e7547cf7ce52e0c58cdc2ce914831e

Zobrazit plný text záznamu

Intra-Graft Abciximab and Verapamil Combined with Direct Stenting is a Safe and Effective Strategy to Prevent Slow-flow and No-Reflow Phenomenon in Saphenous Vein Graft Lesions not Associated with Thrombus

Autor: Joel Lardizabal, Satinder Singh, Brijesh Bhambi, Rasham Sandhu, Sanjiv Sharma

Publikováno v: Recent Patents on Cardiovascular Drug Discovery. 7:152-159

Slow flow and no-reflow phenomenon (SF-NR) in saphenous vein grafts (SVG) stenting is related to the occurrence of distal plaque embolization, platelet activation and microvascular vasospasm. Our article discusses few of the patents related to strate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd07e0c76d72deb4ebee5912573cc525
https://doi.org/10.2174/157489012801227265

Zobrazit plný text záznamu

Bivalirudin (Angiomax) Use during Intracoronary Brachytherapy May Predispose to Acute Closure

Autor: Dean L. Davis, Tetsuo Ishimori, Kirit Desai, Sanjiv Sharma, Carla File, William Nyitray, Pankaj Shukla, Brijesh Bhambi, Geetanjali Sharma

Publikováno v: Scopus-Elsevier

We describe two cases of intracoronary vascular brachytherapy where bivalirudin (Angiomax), employed as an anticoagulant, led to abrupt vessel closure or threatened abrupt closure. Use of bivalirudin (Angiomax) during intracoronary brachytherapy may

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f4cce1ca39049b6d0e76f4015305107
https://doi.org/10.1177/107424840300800i103

Zobrazit plný text záznamu

Extensive fatal intracoronary thrombosis during percutaneous coronary intervention with bivalirudin

Autor: Shirish Patel, Brijesh Bhambi, Sanjiv Sharma, Neil Bhambi, Rohan Sharma, Ashok Behl, Satinder Singh, Rasham Sandhu

Publikováno v: American journal of therapeutics. 21(4)

The authors describe 2 cases of extensive intracoronary thrombus formation leading to acute closure of the left main where bivalirudin (Angiomax) was used as the anticoagulant during percutaneous coronary intervention leading to mortality. Both cases

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b5087719ea5027d2644f44b1fcbe8df
https://pubmed.ncbi.nlm.nih.gov/24513697

Zobrazit plný text záznamu

Differential effects of transforming growth factor-beta 1 and phorbol myristate acetate on cardiac fibroblasts. Regulation of fibrillar collagen mRNAs and expression of early transcription factors

Autor: Brijesh Bhambi, Vikas P. Sukhatme, R. Tomek, Mahboubeh Eghbali, C. Woods

Publikováno v: Circulation Research. 69:483-490

Cardiac fibroblasts are responsible for synthesis and deposition of fibrillar collagen types I and III. Transforming growth factor-beta 1 (TGF-beta 1) has been proved to increase collagen biosynthesis in various systems, both in vivo and in vitro. We

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b17b316e7d67571f8661d3255b644a7
https://doi.org/10.1161/01.res.69.2.483

Zobrazit plný text záznamu

Cardiac fibroblasts are predisposed to convert into myocyte phenotype: specific effect of transforming growth factor beta

Autor: Brijesh Bhambi, Ronald J. Tomek, Mahboubeh Eghbali, Cheryl Woods

Publikováno v: Proceedings of the National Academy of Sciences. 88:795-799

Cardiac fibroblasts are mainly responsible for the synthesis of major extracellular matrix proteins in the heart, including fibrillar collagen types I and III and fibronectin. In this report we show that these cells, when stimulated by transforming g

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0ef648cb5e7a62371c6da40cc7e07c8
https://doi.org/10.1073/pnas.88.3.795

Zobrazit plný text záznamu

Oral midodrine is effective for the treatment of hypotension associated with carotid artery stenting

Autor: Brijesh Bhambi, Joel A. Lardizabal, Sanjiv Sharma

Publikováno v: Journal of cardiovascular pharmacology and therapeutics. 13(2)

Hypotension is commonly encountered during carotid artery stenting (CAS), mediated by vagal stimulation and suppression of sympathetic outflow. Some patients require treatment with intravenous vasopressors (dopamine, nor-epinephrine, or phenylephrine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bcfb8a7160d140fcc38bf929fdb260c
https://pubmed.ncbi.nlm.nih.gov/18495904

Zobrazit plný text záznamu

Successful treatment of hypotension associated with stunned myocardium with oral midodrine therapy

Autor: Brijesh Bhambi, Sanjiv Sharma

Publikováno v: Journal of cardiovascular pharmacology and therapeutics. 10(1)

Myocardial stunning, a reversible decrease in the contractile function of the myocardium after an ischemic insult, often leads to hypotension that requires therapy with intravenous inotropes. We used the oral agent midodrine to treat hypotension that

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ea7443f4edbff1233f703bf3643a4a6
https://pubmed.ncbi.nlm.nih.gov/15821841

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání